Curaleaf Holdings Files 6-K for Q3 2024 Period

Ticker: CURLF · Form: 6-K · Filed: 2024-11-07T00:00:00.000Z

Sentiment: neutral

Topics: reporting, sec-filing, registration

TL;DR

Curaleaf filed a 6-K for Q3 2024, incorporating by reference into its F-10.

AI Summary

Curaleaf Holdings, Inc. filed a Form 6-K on November 7, 2024, reporting for the period ending September 30, 2024. The filing indicates the company is incorporated in A1 and has its principal executive offices in Vancouver, British Columbia, Canada. It also references incorporation by reference into a Form F-10 registration statement.

Why It Matters

This filing provides an update on Curaleaf's reporting status and incorporates previous filings into its registration statement, which is relevant for investors tracking the company's ongoing disclosures.

Risk Assessment

Risk Level: low — This is a routine periodic filing that does not appear to contain new material financial information or significant corporate events.

Key Numbers

Key Players & Entities

FAQ

What is the primary purpose of this Form 6-K filing?

The primary purpose is to report information that Curaleaf Holdings, Inc. has made or will make public, is required to make or has made or will make public to any stock exchange on which it is listed, or is required to publish or has published or will publish inside or outside of Canada, for the month of November 2024.

What period does this filing cover?

This filing is for the period ending September 30, 2024.

What is Curaleaf's Commission File Number?

Curaleaf's Commission File Number is 333-249081.

What is the significance of the incorporation by reference to Form F-10?

Exhibit 99.1 to this Form 6-K is incorporated by reference into the Company's Registration Statement on Form F-10 (File No. 333-269109), indicating that information from this 6-K is part of a larger registration filing.

Where are Curaleaf's principal executive offices located?

Curaleaf's principal executive offices are located at 666 Burrard Street, Suite 1700, Vancouver, British Columbia V6C 2X8, Canada.

From the Filing

0001756770-24-000066.txt : 20241107 0001756770-24-000066.hdr.sgml : 20241107 20241106202416 ACCESSION NUMBER: 0001756770-24-000066 CONFORMED SUBMISSION TYPE: 6-K PUBLIC DOCUMENT COUNT: 7 CONFORMED PERIOD OF REPORT: 20240930 FILED AS OF DATE: 20241107 DATE AS OF CHANGE: 20241106 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Curaleaf Holdings, Inc. CENTRAL INDEX KEY: 0001756770 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 6-K SEC ACT: 1934 Act SEC FILE NUMBER: 333-249081 FILM NUMBER: 241432734 BUSINESS ADDRESS: STREET 1: 420 LEXINGTON AVENUE CITY: NEW YORK STATE: NY ZIP: 10170 BUSINESS PHONE: 781-451-0117 MAIL ADDRESS: STREET 1: 420 LEXINGTON AVENUE CITY: NEW YORK STATE: NY ZIP: 10170 FORMER COMPANY: FORMER CONFORMED NAME: LEAD VENTURES INC. DATE OF NAME CHANGE: 20181023 6-K 1 q3246-kcover.htm 6-K Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of November, 2024 Commission File Number: 333-249081 Curaleaf Holdings, Inc. (Name of Registrant) 666 Burrard Street, Suite 1700, Vancouver, British Columbia V6C 2X8, Canada (Address of Principal Executive Office) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F ☐    Form 40-F ☒ INCORPORATION BY REFERENCE Exhibit 99.1 to this Form 6-K of Curaleaf Holdings, Inc. (the “Company”) are hereby incorporated by reference into the Registration Statement on Form F-10 (File No. 333-269109) of the Company, as amended or supplemented. SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. CURALEAF HOLDINGS, INC. (Registrant) Date: November 6, 2024 By: /s/ Peter Clateman Name: Peter Clateman Title: Chief Legal Officer EXHIBIT INDEX Exhibit Number Description 99.1 Unaudited Condensed Interim Consolidated Financial Statements as of September 30, 2024 and December 31, 2023 and for the Three and Nine Months Ended S eptember 30 , 2024 and 2023 and Management’s Discussion and Analysis of Financial Condition and Results of Operations for the Three and Nine Months Ended September 30 , 2024 and 2023 99.2 CEO Certification of Interim Filings 99.3 CFO Certification of Interim Filings 99.4 Press Release dated November 6 , 2024 EX-99.1 2 q324-exx992xfsandmda.htm EX-99.1 Document Exhibit 99.2 CURALEAF HOLDINGS, INC. Condensed Interim Consolidated Financial Statements (Unaudited) As of September 30, 2024 and December 31, 2023 and For the Three and Nine Months Ended September 30, 2024 and 2023 Page(s) Financial Statements: Condensed Interim Consolidated Balance Sheets (Unaudited) as of September 30, 2024 and December 31, 2023 3 Condensed Interim Consolidated Statements of Operations (Unaudited) for the three and nine months ended September 30, 2024 and 2023 5 Condensed Interim Consolidated Statements of Comprehensive Loss (Unaudited) for the three and nine months ended September 30, 2024 and 2023 6 Condensed Interim Consolidated Statements of Temporary Equity and Shareholders’ Equity (Unaudited) for the nine months ended September 30, 2024 and 2023 7 Condensed Interim Consolidated Statements of Cash Flows (Unaudited) for the nine months ended September 30, 2024 and 2023 8 Notes to Condensed Interim Consolidated Financial Statements (Unaudited) 10 Management’s Discussion and Analysis of Financial Condition and Results of Operations for the three and nine months ended September 30, 2024 and 2023 62 Curaleaf Holdings, Inc.

View on Read The Filing